HPLC determination of chondrosine in mouse blood plasma after intravenous or oral dose

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 8, 2007, Pages 1365-1368

  Kusano, Shuichi ^a   Ootani, Atsuko ^a   Sakai, Shinobu ^b   Igarashi, Naoko ^b   Takeguchi, Atsuko ^b   Toyoda, Hidenao ^b   Toida, Toshihiko ^b  

^a Fuji Sangyo Co Ltd   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Bioavailability; Chondrosine; HPLC determination; Oral dose

Indexed keywords

ACETAMIDE DERIVATIVE; BLOOD EXTRACT; BORIC ACID; CHONDROITIN SULFATE; CHONDROSINE; GLYCOSAMINOGLYCAN; PERCHLORIC ACID; SODIUM HYDROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ASSAY; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; PH;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISACCHARIDES; FLUORESCENT DYES; INJECTIONS, INTRAVENOUS; MALE; MICE; NITRILES; REPRODUCIBILITY OF RESULTS;

EID: 34548052496     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1365     Document Type: Article

References (23)

1. Sarzi-Puttini P., Cimmino M. A., Scarpa R., Caporali R., Parazzini F., Zaninelli A., Atzeni F., Canesi B., Semin. Arthritis Rheum., 35 (Suppl. 1), 1-10 (2005).
2. Scott D., Smith C., Lohmander S., Chard J., Clin. Evid., 10, 1402-1430 (2003).
3. Felson D. T., N. Engl. J. Med., 354, 841-848 (2006).
4. Baker C. L., Jr., Ferguson C. M., Orthopedics., 28, s227-234 (2005).
5. Van Linthoudt D., Gerster J. C., Rev. Med. Suisse Romande., 124, 565-567 (2004).
6. McAlindon T. E., Biggee B. A., Curr. Opin. Rheumatol., 17, 647-652 (2005).
7. Owens S., Wagner P., Vangsness C. T., Jr., J. Knee Surg., 17, 185-193 (2004).
8. Hochberg M. C., N. Engl. J. Med., 354, 795-808 (2006).
9. Caraglia M., Beninati S., Giuberti G., D'Alessandro A. M., Lentini A., Abbruzzese A., Bove G., Landolfi F., Rossi F., Lampa E., Costantino M., Exp. Mol. Med., 37, 476-481 (2005).
10. Monfort J., Nacher M., Montell E., Vila J., Verges J., Benito P., Drugs Exp. Clin. Res., 31, 71-76 (2005).
11. Sakai S., Akiyama H., Sato Y., Yoshioka Y., Linhardt R. J., Goda Y., Maitani T., Toida T., J. Biol. Chem., 281, 19872-19880 (2006).
12. Akiyama H., Sakai S., Linhardt R. J., Goda Y., Toida T., Maitani T., Biochem. J., 382, 269-278 (2004).
13. Sakai S., Akiyama H., Harikai N., Toyoda H., Toida T., Maitani T., Imanari T., Immunol. Lett., 84, 211-216 (2002).
14. Cho S. Y., Sim J. S., Jeong C. S., Chang S. Y., Choi D. W., Toida T., Kim Y. S., Biol. Pharm. Bull., 27, 47-51 (2004).
15. Adebowale A., Du J., Liang Z., Leslie J. L., Eddington N. D., Biopharm. Drug Dispos., 23, 217-225 (2002).
16. Takanashi S., Hirasaka Y., Kawada M., Ishidate M., Chem. Pharm. Bull., 14, 82-86 (1966).
17. Kusano S., Igarashi N., Sakai S., Toida T., Yakugaku Zasshi, 126, 297-300 (2006).
18. Honda S., Suzuki S., Anal. Biochem., 142, 167-174 (1984).
19. Toyoda H., Yamanashi S., Hakamada Y., Shinomiya K., Imanari T., Chem. Pharm. Bull., 37, 1627-1628 (1989).
20. Sakai S., Onose J., Nakamura H., Toyoda H., Toida T., Imanari T., Linhardt R. J., Anal. Biochem., 302, 169-174 (2002).
21. Volpi N., Osteoarthritis Cartilage, 11, 433-441 (2003).
22. Verges J., Castaneda-Hernandez G., Proc. West Pharmacol. Soc., 47, 50-53 (2004).
23. Toyoda H., Kobayashi S., Sakamoto S., Toida T., Imanari T., Biol. Pharm. Bull., 16, 945-947 (1993).